Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefeng Qiu

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Cancer Cell International|March 4, 2022
Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancersHaixiang Qin, Yingqiang Lu, Lin Du, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
Extracellular Matrix Stiffness Regulates Microvascular Stability by Controlling Endothelial Paracrine Signaling to Determine Pericyte FateYali Yu, Yu Leng, Xiuyue Song, et al.
The FEBS Journal|March 11, 2021
SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signalingHaixiang Qin, Yang Yang, Bo Jiang, et al.
Cell Communication and Signaling : CCS|November 29, 2025
DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detectionShun Zhang, Guanchen Zhu, Linfeng Xu, et al.
Scientific Reports|October 30, 2024
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentationSophia L Bürkle, Dejan Kuhn, Tobias Fechter, et al.
Minerva Urology and Nephrology|June 16, 2022
Multicentric experience in Retzius-sparing robot-assisted radical prostatectomy performed by expert surgeons for high-risk prostate cancerAntonio Galfano, Stefano Tappero, Christopher Eden, et al.
Frontiers in Oncology|April 11, 2022
<sup>177</sup>Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East AsiansTing Bu, Lulu Zhang, Fei Yu, et al.
Frontiers in Oncology|April 25, 2022
Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective StudyJunlong Zhuang, Yansheng Kan, Yuwen Wang, et al.
The Journal of Clinical Investigation|August 15, 2024
PRMT5-mediated FUBP1 methylation accelerates prostate cancer progressionWeiwei Yan, Xun Liu, Xuefeng Qiu, et al.
Biomaterials|December 24, 2018
Contribution of bone marrow-derived cells to in situ engineered tissue capsules in a rat model of chronic kidney diseaseTaisiya Bezhaeva, Wouter J Geelhoed, Dong Wang, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Cancer Cell International|March 4, 2022
Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancersHaixiang Qin, Yingqiang Lu, Lin Du, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
Extracellular Matrix Stiffness Regulates Microvascular Stability by Controlling Endothelial Paracrine Signaling to Determine Pericyte FateYali Yu, Yu Leng, Xiuyue Song, et al.
The FEBS Journal|March 11, 2021
SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signalingHaixiang Qin, Yang Yang, Bo Jiang, et al.
Cell Communication and Signaling : CCS|November 29, 2025
DECIPHER-PRAD: an advanced fragmentomics-based cell-free DNA assay for prostate cancer early detectionShun Zhang, Guanchen Zhu, Linfeng Xu, et al.
Scientific Reports|October 30, 2024
A student trained convolutional neural network competing with a commercial AI software and experts in organ at risk segmentationSophia L Bürkle, Dejan Kuhn, Tobias Fechter, et al.
Minerva Urology and Nephrology|June 16, 2022
Multicentric experience in Retzius-sparing robot-assisted radical prostatectomy performed by expert surgeons for high-risk prostate cancerAntonio Galfano, Stefano Tappero, Christopher Eden, et al.
Frontiers in Oncology|April 11, 2022
<sup>177</sup>Lu-PSMA-I&T Radioligand Therapy for Treating Metastatic Castration-Resistant Prostate Cancer: A Single-Centre Study in East AsiansTing Bu, Lulu Zhang, Fei Yu, et al.
Frontiers in Oncology|April 25, 2022
Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective StudyJunlong Zhuang, Yansheng Kan, Yuwen Wang, et al.
The Journal of Clinical Investigation|August 15, 2024
PRMT5-mediated FUBP1 methylation accelerates prostate cancer progressionWeiwei Yan, Xun Liu, Xuefeng Qiu, et al.
Biomaterials|December 24, 2018
Contribution of bone marrow-derived cells to in situ engineered tissue capsules in a rat model of chronic kidney diseaseTaisiya Bezhaeva, Wouter J Geelhoed, Dong Wang, et al.
Pageof 14